Cargando…

Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention

Glycosylated hemoglobin (HbA1c) is a critical measure of glycemic control, which may be a reliable predictor of complications after percutaneous coronary intervention (PCI). This systematic review and meta-analysis evaluates the association between HbA1c levels and clinical outcomes in diabetic pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jia, Cheng, Jing, Zhang, Qian, Qi, Cuijuan, Wang, Tong, Xiao, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902553/
https://www.ncbi.nlm.nih.gov/pubmed/27175711
http://dx.doi.org/10.1097/MD.0000000000003696
_version_ 1782437019132100608
author Zheng, Jia
Cheng, Jing
Zhang, Qian
Qi, Cuijuan
Wang, Tong
Xiao, Xinhua
author_facet Zheng, Jia
Cheng, Jing
Zhang, Qian
Qi, Cuijuan
Wang, Tong
Xiao, Xinhua
author_sort Zheng, Jia
collection PubMed
description Glycosylated hemoglobin (HbA1c) is a critical measure of glycemic control, which may be a reliable predictor of complications after percutaneous coronary intervention (PCI). This systematic review and meta-analysis evaluates the association between HbA1c levels and clinical outcomes in diabetic patients after PCI. Pubmed, Embase, and Cochrane Library databases (dated to December 2015) were screened for relevant studies. Appropriate diabetic cases and controls, assessed using blood HbA1c levels, were extracted, and statistical analysis was conducted using RevMan 5.3 software. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the associations between HbA1c levels and clinical outcomes in diabetic patients after PCI. Ethics review and approval was not necessary because this systematic meta-analysis did not involve any direct human trials or animal experiments. Eight studies that reported HbA1c levels for a total of 3290 diabetic subjects after PCI were included in this meta-analysis. Comprehensive integration and analysis revealed a significant correlation between higher HbA1c levels and the risk of target vessel revascularization progression (OR 1.36, 95% CI 1.03–1.82) and nonfatal myocardial infarction after PCI (OR 2.47, 95% CI 1.38–4.44). However, no significant association was found between HbA1c levels and major adverse cardiovascular events (OR 1.02, 95% CI 0.83–1.27), all-cause mortality (OR 0.73, 95% CI 0.52–1.02), cardiac death (OR 1.12, 95% CI 0.62–2.03), or in-stent thrombosis (OR 0.65, 95% CI 0.23–1.87) among diabetic patients after PCI. Sensitivity analysis indicated a statistically robust result and revealed no publication bias. Our meta-analysis demonstrated that blood HbA1c levels might be associated with higher risks of target vessel revascularization progression and nonfatal myocardial infarction among diabetic patients after PCI. However, further studies with larger sample sizes are required to verify the association.
format Online
Article
Text
id pubmed-4902553
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49025532016-06-27 Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention Zheng, Jia Cheng, Jing Zhang, Qian Qi, Cuijuan Wang, Tong Xiao, Xinhua Medicine (Baltimore) 4300 Glycosylated hemoglobin (HbA1c) is a critical measure of glycemic control, which may be a reliable predictor of complications after percutaneous coronary intervention (PCI). This systematic review and meta-analysis evaluates the association between HbA1c levels and clinical outcomes in diabetic patients after PCI. Pubmed, Embase, and Cochrane Library databases (dated to December 2015) were screened for relevant studies. Appropriate diabetic cases and controls, assessed using blood HbA1c levels, were extracted, and statistical analysis was conducted using RevMan 5.3 software. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the associations between HbA1c levels and clinical outcomes in diabetic patients after PCI. Ethics review and approval was not necessary because this systematic meta-analysis did not involve any direct human trials or animal experiments. Eight studies that reported HbA1c levels for a total of 3290 diabetic subjects after PCI were included in this meta-analysis. Comprehensive integration and analysis revealed a significant correlation between higher HbA1c levels and the risk of target vessel revascularization progression (OR 1.36, 95% CI 1.03–1.82) and nonfatal myocardial infarction after PCI (OR 2.47, 95% CI 1.38–4.44). However, no significant association was found between HbA1c levels and major adverse cardiovascular events (OR 1.02, 95% CI 0.83–1.27), all-cause mortality (OR 0.73, 95% CI 0.52–1.02), cardiac death (OR 1.12, 95% CI 0.62–2.03), or in-stent thrombosis (OR 0.65, 95% CI 0.23–1.87) among diabetic patients after PCI. Sensitivity analysis indicated a statistically robust result and revealed no publication bias. Our meta-analysis demonstrated that blood HbA1c levels might be associated with higher risks of target vessel revascularization progression and nonfatal myocardial infarction among diabetic patients after PCI. However, further studies with larger sample sizes are required to verify the association. Wolters Kluwer Health 2016-05-13 /pmc/articles/PMC4902553/ /pubmed/27175711 http://dx.doi.org/10.1097/MD.0000000000003696 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4300
Zheng, Jia
Cheng, Jing
Zhang, Qian
Qi, Cuijuan
Wang, Tong
Xiao, Xinhua
Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
title Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
title_full Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
title_fullStr Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
title_full_unstemmed Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
title_short Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
title_sort association between glycosylated hemoglobin level and cardiovascular outcomes in diabetic patients after percutaneous coronary intervention
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902553/
https://www.ncbi.nlm.nih.gov/pubmed/27175711
http://dx.doi.org/10.1097/MD.0000000000003696
work_keys_str_mv AT zhengjia associationbetweenglycosylatedhemoglobinlevelandcardiovascularoutcomesindiabeticpatientsafterpercutaneouscoronaryintervention
AT chengjing associationbetweenglycosylatedhemoglobinlevelandcardiovascularoutcomesindiabeticpatientsafterpercutaneouscoronaryintervention
AT zhangqian associationbetweenglycosylatedhemoglobinlevelandcardiovascularoutcomesindiabeticpatientsafterpercutaneouscoronaryintervention
AT qicuijuan associationbetweenglycosylatedhemoglobinlevelandcardiovascularoutcomesindiabeticpatientsafterpercutaneouscoronaryintervention
AT wangtong associationbetweenglycosylatedhemoglobinlevelandcardiovascularoutcomesindiabeticpatientsafterpercutaneouscoronaryintervention
AT xiaoxinhua associationbetweenglycosylatedhemoglobinlevelandcardiovascularoutcomesindiabeticpatientsafterpercutaneouscoronaryintervention